Mayo Clinic Platform Accelerate announces inaugural participants of its new multiyear pathway program

Getty Images ROCHESTER, Minn. — Mayo Clinic Platform today announced that its Accelerate program for healthcare technology companies is now available through a multiyear engagement pathway. The inaugural participants of the multiyear track include 12 companies developing artificial intelligence (AI)-powered solutions to enhance care delivery and healthcare operations. "The Accelerate program was intentionally designed to support digital health companies ready to transform healthcare," says Jamie Sundsbak, director of the Mayo Clinic Platform Accelerate program." As participation continues to grow, the program has evolved to support solutions developers through multiple pathways tailored to their different stages of development." The multiyear pathway is designed for select companies seeking sustained access to Mayo Clinic Platform's discovery environment, data, technology and expertise. Through an extended engagement, participants can work alongside Mayo Clinic Platform's experts and leverage its de-identified clinical data ecosystem to advance the development and validation of their digital health solutions. The 12 companies selected as the first participants in the multiyear pathway are developing AI-enabled solutions that leverage clinical data and advanced analytics to transform healthcare. Cappsule is an AI-enabled ambient monitoring platform designed to support clinical decision-making through continuous, real-world data capture. CerebraAI develops AI-powered software as a medical device that aims to upgrade the diagnostic capability of noncontrast computed tomography imaging, bringing it closer to MRI standards. Clair Health is building a women's health intelligence platform grounded in continuous, direct hormone data. Durotimi AI is a pioneering healthcare technology company dedicated to transforming cancer care through advanced, localized AI. Electrokare is building AI infrastructure for continuous biological intelligence — turning today's snapshot healthcare system into continuous measurement. Floe Health is a clinical reasoning engine for hospital case management. Koroid is an AI-native operating system for healthcare operations. MedLink Global is pioneering AI-powered solutions to transform psychiatric care. OPTT Health is a clinically led AI platform for scalable mental healthcare. PONS aims to make ultrasound accessible to the mass market by addressing the limitations of high-resolution images in the early stages of disease. Radical Health offers a patient-facing second opinion service that allows patients to receive personalized treatment recommendations. Respiree is an AI/machine learning health tech company building state-of-the-art, clinically-validated AI for managing disease progression across healthcare's care continuum. Since its launch in 2022, Accelerate has supported more than 130 companies from around the world. To learn more about the program or to apply for an upcoming cohort, visit Mayo Clinic Platform Accelerate . ### About Mayo Clinic Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news. About Mayo Clinic Platform Mayo Clinic Platform is a strategic initiative of Mayo Clinic that enables collaboration, data-driven innovation and responsible AI development to transform healthcare globally. Mayo Clinic Platform is reimagining healthcare as an ecosystem — one where data, digital solutions and expertise flow seamlessly between innovators and care teams to improve care for patients everywhere. Media contact: Caroline Auger, Mayo Clinic Communications, newsbureau@mayo.edu The post Mayo Clinic Platform Accelerate announces inaugural participants of its new multiyear pathway program appeared first on Mayo Clinic News Network .